Evidence map›Paper›PMID 41928692›Full record

ReviewArtificial organs2026

Standardization of In Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development.

Jutta Arens, Mirko Belliato, Lars Mikael Broman, Johanna C Clauser, Dirk W Donker, Roberto Lorusso, Maximilian Malfertheiner, Sasa Rajsic, Justyna Swol, Leen Vercaemst and 3 more

Abstract readReview
In one paragraph

Review in Artificial organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jutta ArensEngineering Organ Support Technologies, Department of Biomechanical Engineering, Faculty of Engineering Technology, University of Twente, Enschede, the Netherlands.
Mirko BelliatoSC AR2 - Anestesia e Terapia Intensiva Cardiotoracica, Fondazione IRCCS Policlinico San Matteo, Pavia, Aachen, Italy.
Lars Mikael BromanECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
Johanna C ClauserDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, University Hospital Aachen, RWTH Aachen University, Germany.
Dirk W DonkerCardiovascular and Respiratory Physiology, Department of Biomedical Imaging and Sensing, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.
Roberto LorussoCardio-Thoracic Surgery Department - Heart & Vascular Centre, Maastricht University Medical Hospital, Maastricht, the Netherlands.
Maximilian MalfertheinerCenter of Pneumology, Caritas-Krankenhaus St. Maria, Donaustauf, Germany.
Sasa RajsicDepartment of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria.
Justyna SwolDepartment of Respiratory Medicine, Paracelsus Medical University Nuremberg, Nuremberg, Germany.
Leen VercaemstDepartment of Perfusion, University Hospital Leuven, Leuven, Belgium.
Lisa Prahl WittbergFLOW, Department of Engineering Mechanics, Royal Institute of Technology (KTH), Stockholm, Sweden.
EACTS Innovation Committee, Section CPB, ECLS & MCS
EuroELSO Innovation Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance-efficiency, hemocompatibility, and long-term stability. All novel devices, even in early research stages, must undergo rigorous testing and evaluation. Yet, these early evaluations are often conducted under nonstandardized conditions, resulting in data difficult to compare, interpret, or translate into clinical practice. Establishing well-defined, standardized in vitro testing protocols for all ECLS components and devices would represent a major step forward. Such protocols would improve methodological consistency and ensure reproducibility across research groups. This document, developed by an international group of ECLS experts from all disciplines in which such components are designed, developed, and applied, provides clear recommendations and standardized criteria for device testing according to international norms. Adoption of these criteria including the ways of reporting results will foster a unified approach among scientists, engineers, clinicians, and the medical device industry. Ultimately, this common framework will facilitate data interpretation, improve comparability of study results between different groups, making the review of studies more straightforward, as not every aspect of testing requires additional review and discussion, certainly favoring decision-making in the development and application of ECLS technologies.

Indexed as

Extracorporeal Membrane OxygenationMaterials TestingEquipment DesignHumansblood cell damagecannulaECLSECMOextracorporeal life supportextracorporeal membrane oxygenationin vitro testingoxygenatorpumpstandardizationtubing

Identifiers

PMID41928692
PMCPMC13206559

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.